Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed information and analysis at BioHealthInvestor.com: New short-interest data suggest traders are now increasing their…
Having money is not what it used to be. According to several media reports, the billionaire mayor of New York City, Michael Bloomberg, lost millions of dollars in the market downturn. He has apparently…
Here are some of the top stories affecting key drug and biotech stocks this Friday. We also have links through to more detailed coverage and analysis at BioHealthInvestor.com: Biogen Idec Inc. (Nasdaq: BIIB) kicks…
Here are some of the top stories affecting key drug and biotech stocks that have links through to more in-depth coverage and analysis today at the website BioHealthInvestor.com: Rigel Pharmaceuticals Inc.’s (NASDAQ: RIGL) Phase…
These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details and analysis this morning at BioHealthInvestor.com: Amgen Inc’s (Nasdaq: AMGN)’s osteoporosis drug did so…
Here are some of the top stories affecting key drug and biotech stocks that are covered in-depth today at BioHealthInvestor.com: Cigna corp. (NYSE: CI), Aetna Inc. (NYSE: AET), and other managed care companies are…
Managed health care company stocks are rising Tuesday despite press reports that hospitals will contribute $155 billion over 10 years toward insuring the nearly 50 million Americans who do not have coverage. The cuts…
Hansen Medical Inc. (NASDAQ: HNSN) is becoming the Boulevard of Broken Dreams in the land of speculative medical instrument stocks. We gave a volume spike alert at VSInvestor.com on this one, but this situation…
Alnylam (Nasdaq: ALNY) leads a short list of some of the fastest-growing biotech stocks where analyst estimate revisions continue to rise. BioHealth Investor began by analyzing 171 stocks in the biotech sector based on…
It is hard to say whether a person is better off stopping smoking and lessening their chances of a heart attack or killing themselves. Some of the anti-smoking drugs from Pfizer (PFE) and GlaxoSmithKline…
General Electric Company (NYSE: GE) is taking a bold and controversial new step into the field of embryonic stem cell research. The company has signed an exclusive license and alliance pact with Geron Corporation…
Boston Scientific Corporation (NYSE: BSX) is finally getting free from President and Chief Executive Officer Jim Tobin. This was one our top 10 CEO’s to go for 2009 as his tenure has been bad. …
Everyone is trying to figure out who the winners and losers are likely to be under a watered-down healthcare program under the Obama administration and with a Democratic Congress. What is certain is that…
STAAR Surgical Company (NASDAQ: STAA) has been on a roaring run of late. In mid-May this stock was under $1.00. After news of the company getting a nod for its Epiphany cataract lens insertion…
Underscoring just how much big pharma will depend on biotech acquisitions for future revenue, an analysis published by Evaluate Pharma today suggests half of the top 100 drugs worldwide by 2014 – and all…